These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4238016)

  • 21. Radioimmunoassay of human plasminogen and plasmin.
    Rabiner SF; Goldfine ID; Hart A; Summaria L; Robbins KC
    J Lab Clin Med; 1969 Aug; 74(2):265-73. PubMed ID: 4240543
    [No Abstract]   [Full Text] [Related]  

  • 22. Assay methods and standard preparations for plasmin, plasminogen and urokinase in purified systems, 1967-1968.
    Johnson AJ; Kline DL; Alkjaersig N
    Thromb Diath Haemorrh; 1969 Apr; 21(2):259-72. PubMed ID: 4238780
    [No Abstract]   [Full Text] [Related]  

  • 23. Variation in assays of standard SK and plasmin preparations: evidence for and effect of variability of plasmins, plasminogen, and fibrinogen.
    Johnson AJ; Tse A; Skoza L
    Fed Proc; 1966; 25(1):34-41. PubMed ID: 4283648
    [No Abstract]   [Full Text] [Related]  

  • 24. [Proactivator-activator system in human plasma fibrinolysis: studies on the synthetic fibrinolytic system composed of functionally pure fibrinogen, plasminogen and proactivator, separated from human plasma].
    Okamoto U
    Nihon Seirigaku Zasshi; 1972 Mar; 34(3):147-55. PubMed ID: 4262660
    [No Abstract]   [Full Text] [Related]  

  • 25. The influence of age on in vitro plasmin generation in the presence of fibrin monomer.
    Parmar N; Mitchell LG; Berry LR; Andrew M; Chan AK
    Acta Haematol; 2006; 115(3-4):141-51. PubMed ID: 16549888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The plasminogen-plasmin system. 8. On the mechanism of chemical induction of fibrinolysis. Isolation of a latent plasminogen activator from human plasma.
    Tomikawa M; Abiko Y
    Thromb Diath Haemorrh; 1973 Feb; 29(1):50-62. PubMed ID: 4267738
    [No Abstract]   [Full Text] [Related]  

  • 27. Fibrinolytic agents and their effects on the haemostatic system.
    Kluft C
    Klin Wochenschr; 1988; 66 Suppl 12():50-4. PubMed ID: 2964542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The determination of the proactivator of the fibrinolytic system with a quantitative caseinolytic method].
    Spöttl F
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):393-403. PubMed ID: 4232161
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of heparin on plasmin and plasminogen activation].
    Manmi S
    Nihon Ketsueki Gakkai Zasshi; 1971 Oct; 34(5):591-4. PubMed ID: 4261759
    [No Abstract]   [Full Text] [Related]  

  • 30. [Plasmin formation in a fibrin network].
    Kotschy M; Knapik M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(2):167-73. PubMed ID: 4106005
    [No Abstract]   [Full Text] [Related]  

  • 31. The control of plasminogen and plasmin during thrombolytic therapy.
    Blix S
    Acta Med Scand; 1969 Nov; 186(5):479-82. PubMed ID: 4244879
    [No Abstract]   [Full Text] [Related]  

  • 32. Demonstration of low content of fibrinolytic inhibitors in individuals with high fibrinolytic capacity.
    Hedner U; Nilsson IM; Jacobsen CD
    Scand J Clin Lab Invest; 1970 Jun; 25(4):329-36. PubMed ID: 4247664
    [No Abstract]   [Full Text] [Related]  

  • 33. [Separation of plasmin and plasminogen-activator from SK-activatable fraction B of human plasma (author's transl)].
    Yamamoto J
    Nihon Ketsueki Gakkai Zasshi; 1974 Apr; 37(2):107-20. PubMed ID: 4277925
    [No Abstract]   [Full Text] [Related]  

  • 34. Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin.
    Hunt JA; Petteway SR; Scuderi P; Novokhatny V
    Thromb Haemost; 2008 Sep; 100(3):413-9. PubMed ID: 18766256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of fibrin degradation products on fibrinolytic process.
    Yatsenko TA; Rybachuk VM; Yusova OI; Kharchenko SM; Grinenko TV
    Ukr Biochem J; 2016; 88(2):16-24. PubMed ID: 29227597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of N-ethyl-urethan in plasma plasminogen assay.
    Jacobsen CD
    Scand J Clin Lab Invest; 1968; 21(2):182-6. PubMed ID: 4236695
    [No Abstract]   [Full Text] [Related]  

  • 37. Fibrin plate method with reagents purified by affinity chromatography and its use for determination of fibrinolytic and other proteolytic activity in saliva, bile and plasma.
    Norén I; Ramström G; Wallén P
    Haemostasis; 1975; 4(2):110-24. PubMed ID: 1332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Plasminogen and plasmin determination in human plasma].
    Bruhn HD; Müller L; Duckert F
    Schweiz Med Wochenschr; 1968 Oct; 98(42):1650. PubMed ID: 4235242
    [No Abstract]   [Full Text] [Related]  

  • 39. Interaction of streptokinase and human plasminogen. IV. Further gel electrophoretic studies on the combination of streptokinase with human plasminogen or human plasmin.
    De Renzo EC; Boggiano E; Barg WF; Buck FF
    J Biol Chem; 1967 May; 242(10):2428-34. PubMed ID: 4226006
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.
    Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G
    Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.